HURA TuHURA Biosciences, Inc.: Utang jangka cendhak perusahaan

Simbol lan logo merek TuHURA (HURA)

The following quotes for TuHURA Biosciences, Inc. (HURA) on GURU.Markets illustrate the debt dynamics, which currently stand at 0.00. TuHURA Biosciences, Inc. (HURA) specializes in developing advanced cancer vaccines using a tumor-deception method to activate the immune response. The firm's primary asset consists of unique patents for personalized therapy, although final capitalization depends on the results of the final clinical trials.

HURA Silihan lan utang jangka cendhak perusahaan tuhurabio.com (04.07.2022 - 31.10.2026)

HURA (TuHURA Biosciences Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:
Rega saham TuHURA|HURA - Target konsensus
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar TuHURA Biosciences, Inc.|HURA - Total Nilai Perusahaan
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham TuHURA Biosciences|HURA - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi marang Aset Bersih tuhurabio.com|HURA - Nilai Agregat Aset
- rincian utang lan likuiditas:
Total Utang marang Modal TuHURA Biosciences, Inc.|HURA - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas TuHURA|HURA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku TuHURA Biosciences, Inc.|HURA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TuHURA Biosciences|Indikator likuiditas cepet tuhurabio.com
- data bathi lan kelipatan valuasi:
HURA - Bathi sawise mbayar pajeg
Analisis kabeh metrik perusahaan:HURA - tuhurabio.com
Produk sing diprodhuksi TuHURA Biosciences, Inc.

Experienced investors filter blue-chip assets through liquidity and debt sustainability analysis. This metric measures obligations maturing within one year, determining the business's sensitivity to changes in borrowing costs. The current value of 0.00 reflects the financial burden associated with upgrading cryogenic equipment and maintaining laboratories. A reduction in this indicator minimizes the risk of capital drawdowns. Short-term debt load dynamics confirm the liquidity management strategy of TuHURA Biosciences (HURA).

Perusahaan pesaing

BeiGene - Utang jangka cendhak perusahaan|Halozyme Therapeutics, Inc. (HALO) - Kewajiban jangka cendhak perusahaan|RVMD: Utang jangka cendhak perusahaan|Utang jangka cendhak Ascentage Pharma Corp (AAPG)|Utang jangka cendhak perusahaan CG Oncology, Inc.|URGN: Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ERAS (Erasca Corp)|DCTH - Kewajiban jangka cendhak perusahaan|YMAB: Kewajiban jangka cendhak perusahaan|AURA - Utang jangka cendhak perusahaan|candeltx.com (CADL) - Utang jangka cendhak perusahaan|Accuray Inc - Silihan lan utang jangka cendhak perusahaan|SLS (SELLAS Life Sciences Group, Inc.) - Utang jangka cendhak perusahaan|Utang jangka cendhak Actuate Therapeutics Inc ACTU|Kewajiban jangka cendhak perusahaan CTOR (Citius Oncology, Inc.)|Gedhene kewajiban jangka cendhak TARA|Fate Therapeutics - Kewajiban jangka cendhak perusahaan|Utang jangka cendhak perusahaan Aadi Bioscience, Inc. WHWK|TScan - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan CSBR (Champions Oncology)|XBIT (xbiotech.com) - Kewajiban jangka cendhak perusahaan|CEL-SCI (CVM) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan OS Therapies|RADX: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ARTV|Utang jangka cendhak perusahaan adlainortye.com (ANL)|Veru Inc. - Kewajiban jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan TPST|Xilio - Utang jangka cendhak perusahaan|RENB: Utang jangka cendhak perusahaan|MURA: Utang jangka cendhak perusahaan|KAPA - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan OnKure Therapeutics, Inc.|Utang jangka cendhak CytoMed GDTC|Utang jangka cendhak perusahaan Curis, Inc. (CRIS)|Gunggunge utang jangka cendhak apollomicsinc.com|Utang jangka cendhak perusahaan THAR (Tharimmune Corp)|ADVB - Kewajiban jangka cendhak perusahaan|Genprex, Inc. - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak Calidi Biotherapeutics CLDI|SBFM: Utang jangka cendhak perusahaan|Utang jangka cendhak Xenetic Biosciences, Inc. (XBIO)|Utang jangka cendhak perusahaan Salarius|Tanggungan utang jangka cendhak perusahaan PPBT (Kitov Pharma)|Utang jangka cendhak perusahaan AONC|Kewajiban jangka cendhak perusahaan beigene.com BGNE|Utang jangka cendhak perusahaan CKPT (Checkpoint Therapeutics, Inc.)|Elevation Oncology Inc. (ELEV) - Utang jangka cendhak|ICAD - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak Ikena Oncology, Inc. IKNA|NTBL (Notable Labs, Ltd.) - Kewajiban jangka cendhak perusahaan|Viracta Therapeutics, Inc. - Silihan lan utang jangka cendhak perusahaan|MOR (MorphoSys) - Utang jangka cendhak perusahaan|NAYA Biosciences Inc (NAYA) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan Ascentage Pharma Group Ltd (AAPGV)